Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Rexall Met-Rx Acquisition Brings Sport Supplement Marketing Power

This article was originally published in The Tan Sheet

Executive Summary

Rexall Sundown's planned $108 mil. acquisition of Met-Rx Nutrition would give the vitamin, mineral and supplement powerhouse a strong foothold in the sports nutritional category and an enhanced retail presence in health food and fitness channels.

You may also be interested in...



Numico Supplement Sales Up Over 1300% Due To GNC, Rexall Acquisitions

General Nutrition Companies' U.S. same-store sales increased 9.3% in the first half of 2000, according to data recently made available by parent company Royal Numico. Same-store sales for GNC outlets overseas rose 13.2% compared to the first half of 1999, Numico reported.

Numico Supplement Sales Up Over 1300% Due To GNC, Rexall Acquisitions

General Nutrition Companies' U.S. same-store sales increased 9.3% in the first half of 2000, according to data recently made available by parent company Royal Numico. Same-store sales for GNC outlets overseas rose 13.2% compared to the first half of 1999, Numico reported.

Numico Supplement Sales Up Over 1300% Due To GNC, Rexall Acquisitions

General Nutrition Companies' U.S. same-store sales increased 9.3% in the first half of 2000, according to data recently made available by parent company Royal Numico. Same-store sales for GNC outlets overseas rose 13.2% compared to the first half of 1999, Numico reported.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090705

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel